Grown Rogue International (GRUSF) Net Margin (2013 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Net Margin of 29.51% in Q1 2026, down 197.05% quarter-over-quarter from 30.41% in Q4 2025, and down 3789.0% on a YoY basis from 0.8% in Q1 2025.
Grown Rogue International (GRUSF) Net Margin (2013 - 2026) Analysis & Trends
Grown Rogue International's Net Margin history runs 12 years deep, the most recent figure standing at 29.51% for Q1 2026.
- In Q1 2026, Net Margin fell 3789.0% year-over-year to 29.51%; the TTM figure through Mar 2026 stood at 41.6% (up 179279673.0% YoY), while the FY2025 annual figure was 1.4%, up 5863.0% from the prior year.
- Net Margin was 29.51% for Q1 2026 at Grown Rogue International, down from 30.41% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 50.31% in Q3 2025 to a low of 15577660.63% in Q3 2024.
- Historically, Net Margin has averaged 1112695.18% across 5 years, with a median of 2.6% in 2023.
- The sharpest annual moves came in 2025 and 2026: Net Margin soared 1557771093 bps in 2025, then plunged 3789 bps in 2026.
- A 5-year view of Net Margin shows it stood at 11.33% in 2022, then soared by 256 bps to 17.67% in 2023, then tumbled by 88163014 bps to 15577660.63% in 2024, then soared by 100 bps to 30.41% in 2025, then plunged by 197 bps to 29.51% in 2026.
- The last three Net Margin figures came in at 29.51% (Q1 2026), 30.41% (Q4 2025), and 50.31% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -29.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.51% |
| Dec 31, 2025 | 30.41% |
| Sep 30, 2025 | 50.31% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 8.37% |
| Sep 30, 2024 | -15,577,660.63% |
| Jun 30, 2024 | -99.62% |
| Mar 31, 2024 | -63.10% |
| Dec 31, 2023 | 17.67% |
| Oct 31, 2023 | -7.80% |
| Jul 31, 2023 | 5.21% |
| Apr 30, 2023 | 6.88% |
| Jan 31, 2023 | 20.57% |
| Jan 31, 2022 | -11.33% |
| Jul 31, 2021 | -1.80% |
| Apr 30, 2021 | -92.77% |
| Jan 31, 2021 | -102.42% |
| Jul 31, 2020 | -120.73% |
| Apr 30, 2020 | -108.81% |
| Jan 31, 2020 | -21.12% |